Nature, the world's premiere science journal, seems to finally understand what Rainbow Coral Corp. has known for some time: The cell-growth technology pioneered by RBCC partner n3D Biosciences has the potential to completely revolutionize cellular research.
n3D's magnetic levitation technology was the subject of a feature article in the journal's April issue titled "A Better Brew." The system allows researchers at university laboratories and pharmaceutical companies to grow three-dimensional, lifelike microtissues similar enough to those found within the body to be used in in vivo drug-testing models. RBCC signed a joint venture agreement to help market and develop the technology last year.
The abstract of the article is available now at n3D's website www.n3dbio.com/a-better-brew-nature-tech....
According to RBCC CEO Patrick Brown, the high-profile feature is certain to spread the word on n3D's groundbreaking magnetic levitation system to labs across the globe at a time when researchers are eagerly adopting and evaluating 3D cell-growth formats.
"We strongly believe that n3D's levitation technology is the future of cellular research," Brown emphasized. "We anticipate an explosion of interest in the company and its products as a result of this terrific Nature article."
Rainbow BioSciences, RBCC's biotech division, signed a joint venture agreement with n3D last year to help develop and market the Bio-Assembler. For more information on this and other biotech initiatives, visit rainbowbiosciences.com/investors.html.
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net